Published in Ocular Surface

A Step-By-Step Approach to Epiphora

This is editorially independent content
4 min read

Join Drs. Dierker and Lappin to review how to identify and manage epiphora, lacrimal drainage system obstruction, and knowing when to inspect closer.

Cory Lappin, OD, MS, FAAO of the Dry Eye Center of Ohio, joins host Damon Dierker, OD, FAAO of Eye Surgeons of Indiana in Indianapolis on Dry Eye Fireside Chat to walk through a systematic, three-category approach to epiphora and share a case that ended in the operating room.
Epiphora is one of the more challenging and commonly misunderstood complaints in a dry eye practice. Drs. Lappin and Dierker organize the differential into three categories: dry eye, mechanical causes, and outflow obstruction. Working through these categories, every time, is how you avoid months of chasing the wrong diagnosis.

Fast facts: Sarcoidosis and lacrimal sac obstruction

  • Sarcoidosis accounted for 2.1% of granulomatous findings across 377 consecutive dacryocystorhinostomy (DCR) biopsy specimens.1
  • Granulomatous inflammation of the lacrimal sac represents 1 to 2% of all DCR specimens; the majority is attributed to systemic sarcoidosis.2
  • Sarcoidosis affects Black Americans at approximately 3 times the incidence of white Americans, with rates as high as 35.5 per 100,000.3
  • Clinical presentation is indistinguishable from any other nasolacrimal duct obstruction. The diagnosis is made at biopsy, not at the slit lamp.
  • Management of the underlying systemic disease runs concurrent with surgical planning. In this case, the second eye DCR was held pending better systemic control.

A surprising diagnosis hiding in the drainage system

The conversation centers on a patient Dr. Lappin had been managing for years: a woman in her 60s with known dry eye disease who suddenly developed bilateral epiphora, and eventually needed a DCR. A careful evaluation of the potential underlying causes led to a definitive, and surprising, diagnosis.
When Dr. Lappin’s patient developed bilateral epiphora, a dry eye flare was a potential explanation, but despite intensified dry eye treatment, her epiphora did not respond. She had no apparent external mechanical causes—no lid malposition or excessive laxity, punctal ectropion, or conjunctivochalasis.
He moved to outflow. Irrigation of the lacrimal drainage system yielded minimal flow and no relief. At this point a more extensive examination of the lacrimal drainage system was warranted, and he referred to oculoplastics.
Dr. Lappin’s patient was found to have a complete obstruction of the lacrimal sac requiring dacryocystorhinostomy. However, this is where the case took an interesting turn. In addition to dry eye disease, his patient also had sarcoidosis. When the tissue was biopsied, the answer was definitive: non-caseating granulomas from her sarcoidosis had infiltrated the lacrimal sac wall.

Clinical considerations for sarcoidosis of the lacrimal sac

Lacrimal sac involvement is not how most clinicians think about sarcoidosis. Its typical anterior segment manifestations are well documented—uveitis, conjunctival nodules, keratoconjunctivitis sicca. The lacrimal drainage system is a different conversation entirely, and rare enough that it stays off the differential until the pathologist puts it in front of you.
There are no external signs that distinguish lacrimal sac sarcoidosis from any other obstruction. The presentation is the same: epiphora, possible dacryocystitis, failed irrigation. The diagnosis is made in the operating room, not at the slit lamp.
In the case of Dr. Lappin’s patient, the co-managing oculoplastics specialist held the second eye surgery pending better systemic control of her sarcoidosis before proceeding, which is the correct sequence: surgical planning does not move ahead of disease management.
For any patient who presents with epiphora, the lacrimal drainage system needs to be methodically evaluated. Do not chase dry eye treatments indefinitely or wait for dacryocystitis to develop before assessing the patency of the system. Dilation and irrigation is the gate. If it fails, oculoplastics is the next call. Dr. Dierker emphasized that he has almost never regretted doing a probe and irrigation because it is both diagnostic and therapeutic.

Key takeaways

  • Work through the potential causes of epiphora systemically: identify any mechanical abnormalities, determine if outflow obstruction is present, and rule out dry eye as a causative or contributing factor. Every time.
  • Dry eye is a common cause of epiphora, but other causes must be ruled out, especially if it does not respond to traditional dry eye treatment.
  • Punctal ectropion and conjunctivochalasis are the two most commonly missed mechanical causes. Look for them deliberately.
  • In some cases, dilation and irrigation gives you more clinical information in 5 minutes than any additional dry eye intervention. Do not skip it.
  • Epiphora itself can develop for numerous reasons. Whether caused by excessive reflex tear production due to dry eye, nasolacrimal duct obstruction associated with aging, or an incredibly rare finding such formation of granulomas in the lacrimal sac, it is imperative to identify the underlying cause.

Conclusion

Watch the full conversation with Drs. Lappin and Dierker for the complete three-category exam framework, their step-by-step approach to dilation and irrigation technique, and the clinical decision points that led from a suspected dry eye flare to an operating room diagnosis.
For more on building a systematic ocular surface workup, read Dr. Lappin’s guide: The Simple Dry Eye Workup for Primary Care Optometrists.
  1. Anderson NG, Wojno TH, Grossniklaus HE. Clinicopathologic findings from lacrimal sac biopsy specimens obtained during dacryocystorhinostomy. Ophthalmic Plast Reconstr Surg. 2003;19(3):173–176. doi:10.1097/01.iop.0000066646.59045.5a. PMID: 12918549.
  2. Singh S, Gandhi J, Shrivastava R, Gupta V. Isolated noncaseating granulomatous inflammation of the lacrimal sac masquerading as a malignancy. Saudi J Ophthalmol. 2022;35(3):269–272. doi:10.4103/SJOPT.SJOPT_15_21.
  3. Baughman RP, Field S, Costabel U, et al. Sarcoidosis in America: analysis based on health care use. Ann Am Thorac Soc. 2016;13(8):1244–1252. doi:10.1513/AnnalsATS.201603-183OC.
Damon Dierker, OD, FAAO
About Damon Dierker, OD, FAAO

Dr. Dierker is Director of Optometric Services at Eye Surgeons of Indiana, an adjunct faculty member at the Indiana University School of Optometry, and Immediate Past President of the Indiana Optometric Association. Dr. Dierker is the Co-Founder and Program Chair of Eyes On Dry Eye, the largest event for eyecare professionals in the industry. He has made significant contributions to raising awareness of dry eye and ocular surface disease in the eyecare community, including the development of Dry Eye Boot Camp and other content resources across dozens of publications.

Damon Dierker, OD, FAAO
Cory J. Lappin, OD, MS, FAAO
About Cory J. Lappin, OD, MS, FAAO

Dr. Cory J. Lappin is a native of New Philadelphia, Ohio and received his Bachelor of Science degree from Miami University, graduating Phi Beta Kappa with Honors with Distinction. He earned his Doctor of Optometry degree from The Ohio State University College of Optometry, where he concurrently completed his Master of Science degree in Vision Science. At the college he served as Class President and was a member of Beta Sigma Kappa Honor Society. Following graduation, Dr. Lappin continued his training by completing a residency in Ocular Disease at the renowned Cincinnati Eye Institute in Cincinnati, Ohio.

Dr. Lappin has been recognized for his clinical achievements, receiving the American Academy of Optometry Foundation Practice Excellence award. He has also been actively engaged in research, being selected to take part in the NIH/NEI T35 research training program and receiving the Vincent J. Ellerbrock Memorial Award in recognition of accomplishments in vision science research.

Dr. Lappin practices at Phoenix Eye Care and the Dry Eye Center of Arizona in Phoenix, Arizona, where he treats a wide variety of ocular diseases, with a particular interest in dry eye and ocular surface disease. He is a Fellow of the American Academy of Optometry, a member of the American Optometric Association, and serves on the Board of Directors for the Arizona Optometric Association. He is also a member of the Tear Film and Ocular Surface Society (TFOS) and volunteers with the Special Olympics Opening Eyes program.

Cory J. Lappin, OD, MS, FAAO
💙 Dry Eye Fireside Chat
Bausch + Lomb Blink